1. Home
  2. GHRS vs AMTB Comparison

GHRS vs AMTB Comparison

Compare GHRS & AMTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • AMTB
  • Stock Information
  • Founded
  • GHRS 2018
  • AMTB 1979
  • Country
  • GHRS Ireland
  • AMTB United States
  • Employees
  • GHRS N/A
  • AMTB N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • AMTB Major Banks
  • Sector
  • GHRS Health Care
  • AMTB Finance
  • Exchange
  • GHRS Nasdaq
  • AMTB Nasdaq
  • Market Cap
  • GHRS 960.2M
  • AMTB 837.4M
  • IPO Year
  • GHRS 2021
  • AMTB N/A
  • Fundamental
  • Price
  • GHRS $14.38
  • AMTB $19.60
  • Analyst Decision
  • GHRS Strong Buy
  • AMTB Buy
  • Analyst Count
  • GHRS 8
  • AMTB 4
  • Target Price
  • GHRS $30.63
  • AMTB $24.00
  • AVG Volume (30 Days)
  • GHRS 353.0K
  • AMTB 208.7K
  • Earning Date
  • GHRS 09-02-2025
  • AMTB 07-23-2025
  • Dividend Yield
  • GHRS N/A
  • AMTB 1.81%
  • EPS Growth
  • GHRS N/A
  • AMTB N/A
  • EPS
  • GHRS N/A
  • AMTB 0.09
  • Revenue
  • GHRS N/A
  • AMTB $305,477,000.00
  • Revenue This Year
  • GHRS N/A
  • AMTB $57.57
  • Revenue Next Year
  • GHRS N/A
  • AMTB $8.91
  • P/E Ratio
  • GHRS N/A
  • AMTB $222.62
  • Revenue Growth
  • GHRS N/A
  • AMTB N/A
  • 52 Week Low
  • GHRS $6.00
  • AMTB $16.21
  • 52 Week High
  • GHRS $20.50
  • AMTB $26.24
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 46.75
  • AMTB 53.58
  • Support Level
  • GHRS $12.81
  • AMTB $19.54
  • Resistance Level
  • GHRS $15.28
  • AMTB $20.64
  • Average True Range (ATR)
  • GHRS 1.49
  • AMTB 0.61
  • MACD
  • GHRS -0.41
  • AMTB -0.10
  • Stochastic Oscillator
  • GHRS 20.60
  • AMTB 25.53

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About AMTB Amerant Bancorp Inc.

Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.

Share on Social Networks: